Foundation Medicine prices upsized IPO at $18, above the range

By
A A A

Foundation Medicine, which offers diagnostic cancer analyses that provide patient specific data for physicians, raised $106 million by offering 5.9 million shares (up from an expected 5.0 million) at $18, above the range of $14 to $16. Foundation Medicine plans to list on the NASDAQ under the symbol FMI. Foundation Medicine initially filed confidentially on 6/24/2013. Goldman Sachs and J.P. Morgan acted as lead managers on the deal.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks: FMI

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Stocks

Referenced

Most Active by Volume

97,697,947
  • $6.8177 ▲ 14.78%
95,347,376
  • $11.66 ▲ 10.73%
84,595,161
  • $3.43 ▲ 1.48%
71,790,837
  • $36.65 ▲ 2.81%
45,310,664
  • $40.04 ▲ 6.18%
38,889,560
  • $6.57 ▼ 1.79%
37,134,304
  • $15.385 ▼ 0.74%
35,498,345
  • $98.725 ▼ 0.30%
As of 7/29/2014, 03:19 PM